Infrequent mutations of the TP53 gene and no amplification of the MDM2 gene in hepatoblastomas

被引:0
|
作者
Ohnishi, H
Kawamura, M
Hanada, R
Kaneko, Y
Tsunoda, Y
Hongo, T
Bessho, F
Yokomori, K
Hayashi, Y
机构
[1] UNIV TOKYO, FAC MED, DEPT PEDIAT, BUNKYO KU, TOKYO 113, JAPAN
[2] UNIV TOKYO, DEPT PEDIAT SURG, TOKYO, JAPAN
[3] SAITAMA CHILDRENS MED CTR, DEPT HEMATOL & ONCOL, IWATSUKI, SAITAMA, JAPAN
[4] SAITAMA CANC CTR HOSP, DEPT LAB MED, INA, SAITAMA, JAPAN
[5] SHOWA UNIV, SCH MED, DEPT SURG, TOKYO 142, JAPAN
[6] HAMAMATSU UNIV SCH MED, DEPT PEDIAT, SHIZUOKA, JAPAN
来源
GENES CHROMOSOMES & CANCER | 1996年 / 15卷 / 03期
关键词
D O I
10.1002/(SICI)1098-2264(199603)15:3<187::AID-GCC8>3.0.CO;2-Z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
We have investigated the mutation of the TP53 gene in hepatoblastomas (HBLs) by using polymerase chain reaction-single strand conformation polymorphism and direct sequencing in 38 HBL tumor samples and in two HBL cell lines. We detected the TP53 gene mutation in an anaplastic hepatoblastoma cell line, but no aberration of the TP53 gene (exons 5-9) was found in tumor samples and in the other HBL cell line. The mutation of the cell line was a missense mutation from GAC (asparagine) to CAC (histidine) at codon 281, which was different from the G-to-T transversion of codon 249 that is frequently found in adult hepatocellular carcinomas (HCCs). In addition, we performed Southern blot analysis of the MDM2 gene, but we did not find MDM2 gene amplification in 19 cases tested. Our results suggest that, in contrast to the findings in HCCs in adults, TP53 gene aberrations are not involved in the development or progression of HBLs in children. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:187 / 190
页数:4
相关论文
共 50 条
  • [31] Profile of TP53 gene mutations in sinonasal cancer
    Holmila, Reetta
    Bornholdt, Jette
    Suitiala, Tuula
    Cyr, Diane
    Dictor, Michael
    Steiniche, Torben
    Wolff, Henrik
    Wallin, Hakan
    Luce, Daniele
    Husgafvel-Pursiainen, Kirsti
    MUTATION RESEARCH-FUNDAMENTAL AND MOLECULAR MECHANISMS OF MUTAGENESIS, 2010, 686 (1-2) : 9 - 14
  • [32] Amplification and overexpression of mdm2 gene in ependymomas
    Suzuki, SO
    Iwaki, T
    MODERN PATHOLOGY, 2000, 13 (05) : 548 - 553
  • [33] The role of TP53 and MDM2 polymorphisms in TP53 mutagenesis and risk of non-melanoma skin cancer
    Almquist, Lindsay M.
    Karagas, Margaret R.
    Christensen, Brock C.
    Welsh, Marleen M.
    Perry, Ann E.
    Storm, Craig A.
    Nelson, Heather H.
    CARCINOGENESIS, 2011, 32 (03) : 327 - 330
  • [34] MDM2 GENE AMPLIFICATION IN METASTATIC OSTEOSARCOMA
    LADANYI, M
    CHA, C
    LEWIS, R
    JHANWAR, SC
    HUVOS, AG
    HEALEY, JH
    CANCER RESEARCH, 1993, 53 (01) : 16 - 18
  • [35] TP53 gene mutations in Hodgkin lymphoma are infrequent and not associated with absence of Epstein-Barr virus
    Maggio, EM
    Stekelenburg, E
    Van den Berg, A
    Poppema, S
    INTERNATIONAL JOURNAL OF CANCER, 2001, 94 (01) : 60 - 66
  • [36] Mdm2 gene amplification in gastric cancer correlation with expression of mdm2 protein and p53 alterations
    Günther, T
    Schneider-Stock, R
    Häckel, C
    Kasper, HU
    Pross, M
    Hackelsberger, A
    Lippert, H
    Roessner, A
    MODERN PATHOLOGY, 2000, 13 (06) : 621 - 626
  • [37] MDM2 gene amplification in esophageal carcinoma
    Michalk, Maike
    Meinrath, Jeannine
    Kuenstlinger, Helen
    Koitzsch, Ulrike
    Drebber, Uta
    Merkelbach-Bruse, Sabine
    Bollschweiler, Elfriede
    Kloth, Michael
    Hartmann, Wolfgang
    Hoelscher, Arnulf
    Quaas, Alexander
    Grimminger, Peter P.
    Odenthal, Margarete
    ONCOLOGY REPORTS, 2016, 35 (04) : 2223 - 2227
  • [38] MDM2 gene amplification as a predictive biomarker for the MDM2 inhibitor milademetan
    Tirunagaru, Vijaya G.
    Gounder, Mrinal M.
    Kumar, Prasanna R.
    Hong, David S.
    Doebele, Robert C.
    MOLECULAR CANCER THERAPEUTICS, 2021, 20 (12)
  • [39] P53 GENE-MUTATIONS AND MDM2 AMPLIFICATION ARE UNCOMMON IN PRIMARY CARCINOMAS OF THE UTERINE CERVIX
    KESSIS, TD
    SLEBOS, RJ
    HAN, SM
    SHAH, K
    BOSCH, XF
    MUNOZ, N
    HEDRICK, L
    CHO, KR
    AMERICAN JOURNAL OF PATHOLOGY, 1993, 143 (05): : 1398 - 1405
  • [40] ONCOGENE AMPLIFICATION IN UROTHELIAL CANCERS WITH P53 GENE MUTATION OR MDM2 AMPLIFICATION
    HABUCHI, T
    KINOSHITA, H
    YAMADA, H
    KAKEHI, Y
    OGAWA, O
    WU, WJ
    TAKAHASHI, R
    SUGIYAMA, T
    YOSHIDA, O
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1994, 86 (17) : 1331 - 1335